A Phase IV, Single-Centre, Observer-Blind, Controlled, Randomized Study to Compare the Safety and Immunogenicity of Fluvirin® to Influvac® Administered to Healthy Children 3 to 12 Years of Age

To evaluate the immunogenicity of one 0.5mL and two 0.5mL intramuscular (IM) injections of FLUVIRIN® and Agrippal® administered 4 weeks apart